Bayer outsources some small molecule research activity

11 February 2020

Leverkusen-headquartered Bayer (BAYN: DE) has agreed a deal with a fellow German company, Nuvisan, to transfer a large part of its Berlin-based small molecule research unit.

Nuvisan is a contract research organization (CRO) which offers clinical studies, laboratory services and contract manufacturing with several sites and clinics in Germany and France.

The strategic partnership will kick off a new research entity to be established by Nuvisan in Berlin, while enabling Bayer to focus on the flexibility and productivity of its R&D operating model.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK